Skip to main content
Antihypertensive Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Antihypertensive Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Jul 2024 143 Pages SKU: IRTNTR74202

Market Overview at a Glance

$0.01 tr
Market Opportunity
3.27%
CAGR
3.13
YoY growth 2023-2024(%)

Antihypertensive Drugs Market Size 2024-2028

The antihypertensive drugs market size is forecast to increase by USD 6.23 billion at a CAGR of 3.27% between 2023 and 2028.

  • The market is experiencing significant growth due to several key factors. The availability of a wide range of drugs catering to various patient needs is a major market driver. Additionally, the increasing adoption of personalized medicine is fueling market growth as healthcare providers look for more effective and targeted treatments for their patients. Another trend influencing the market is the advent of wearable defibrillators and other advanced technologies that enable early detection and intervention for hypertension. These developments offer new opportunities for market participants to innovate and meet the evolving needs of patients. However, challenges such as the high cost of treatment and the presence of generic alternatives continue to pose significant hurdles for market growth.
  • Despite these challenges, the market is expected to witness robust growth In the coming years, driven by the aforementioned trends and the increasing prevalence of hypertension worldwide.

    • What will be the Size of the Antihypertensive Drugs Market During the Forecast Period?

    Antihypertensive Drugs Market Size

     Request Free Sample

  • The market encompasses a diverse range of pharmaceutical products designed to manage and reduce elevated blood pressure levels. Key therapeutic classes include diuretics, ACE inhibitors, vasodilators, calcium channel blockers, and beta-adrenergic blockers. The global market is driven by the growing prevalence of hypertension, particularly among the geriatric population, and the associated health risks. Lifestyle factors such as sedentary living and poor diet also contribute to market growth. Market dynamics are influenced by patent expirations, leading to increased competition and price erosion. Distribution channels include retail pharmacies, hospital pharmacies, e-commerce websites, and online drug stores. Hospitals remain a significant market for antihypertensive drugs due to their role in managing acute and chronic conditions.
  • Market trends include the development of combination therapies and the increasing use of digital health technologies to improve patient outcomes.

    • How is this Antihypertensive Drugs Industry segmented and which is the largest segment?

    The antihypertensive drugs industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    • Type
      • Systemic hypertension
      • Pulmonary hypertension
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • UK
      • Asia
        • China
        • Japan
      • Rest of World (ROW)

      By Type Insights

      • The systemic hypertension segment is estimated to witness significant growth during the forecast period.

      Antihypertenisve drugs, primarily diuretics and vasodilators, play a significant role in managing systemic hypertension. Diuretics, such as hydrochlorothiazide, furosemide, and spironolactone, are widely used due to their effectiveness in reducing blood volume, cardiac output, and systemic vascular resistance. Adrenergic blockers, including prazosin, terazosin, doxazosin, and trimazosin, are another therapeutic class used for producing vasodilation. Additionally, ACE inhibitors and ARBs are employed for treating systemic hypertension. The geriatric population, with a sedentary lifestyle, contributes to the increasing demand for these medications. Patent expirations of major brands have led to the emergence of generic alternatives in retail pharmacies, hospital pharmacies, e-commerce platforms, and online drug stores.

      Calcium channel blockers and beta-adrenergic blockers are other antihypertensive drugs used in clinical practice.

      Antihypertensive Drugs Market Size

      Get a glance at the  Antihypertensive Drugs Industry report of share of various segments Request Free Sample

      The Systemic hypertension segment was valued at USD 28.07 billion in 2018 and showed a gradual increase during the forecast period.

      Regional Analysis

      • North America is estimated to contribute 55% to the growth of the global market during the forecast period.

      Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

      Antihypertensive Drugs Market Share by Geography

      For more insights on the market share of various regions, Request Free Sample

      The market in North America is experiencing growth due to increased awareness of hypertension and the availability of various antihypertensive medications. The US and Canada have a significant focus on hypertension education and prevention, with organizations like the CDC and Hypertension Canada promoting awareness. The market's expansion is also driven by the presence of major pharmaceutical companies offering branded and generic antihypertensive drugs, including diuretics such as Thiazide diuretics (Hydrochlorothiazide, Chlorthalidone, Indapamide), ACE inhibitors, vasodilators, calcium channel blockers, and beta-adrenergic blockers. The market's growth is further supported by a well-established regulatory framework for drug approvals. Antihypertensive drugs are available through various channels, including retail pharmacies, hospital pharmacies, e-commerce websites, online drug stores, and hospitals.

      Key therapeutic classes include Diuretics, ACE inhibitors, Calcium channel blockers, Beta-adrenergic blockers, and Vasodilators. The geriatric population, with a higher prevalence of hypertension, also contributes to market growth. Sedentary lifestyles and patent expirations are other factors influencing market dynamics.

      Market Dynamics

      Our  researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

      What are the key market drivers leading to the rise In the adoption of Antihypertensive Drugs Industry?

      Availability of wide range of drugs is the key driver of the market.

    • Antihypertensive drugs are a crucial therapeutic class used for managing hypertension, a condition characterized by elevated blood pressure. These medications work by reducing blood volume, decreasing systemic vascular resistance, and suppressing cardiac output. Diuretics, such as Thiazide diuretics (Hydrochlorothiazide, Chlorthalidone, Indapamide), are a common type of antihypertensive drug that decrease blood volume by increasing urine output. Vasodilators, like ACE inhibitors and beta-blockers (Beta-adrenergic blockers), dilate blood vessels by relaxing smooth muscle. Calcium channel blockers also function as vasodilators, while centrally acting sympatholytic drugs, such as those used to treat hypertension, block sympathetic activity. The market is influenced by various factors, including the growing geriatric population and the increasing prevalence of sedentary lifestyles.
    • Patent expirations of key drugs, like Valsartan tablets, have led to increased competition In the market. Antihypertensive drugs are available through various channels, including retail pharmacies, hospital pharmacies, e-commerce websites, and online drug stores. Major players In the industry include Dr. Reddy's Laboratories, but this text will not list specific companies. In conclusion, the market is driven by the increasing prevalence of hypertension and the need for effective treatments. Diuretics, vasodilators, cardioinhibitory drugs, and centrally acting sympatholytic drugs are the primary types of antihypertensive drugs used to manage hypertension. The market is influenced by various factors, including the growing geriatric population, patent expirations, and the increasing use of various distribution channels, such as retail pharmacies, hospital pharmacies, e-commerce websites, and online drug stores.

      • What are the market trends shaping the Antihypertensive Drugs Industry?

      Growing adoption of personalized medicine is the upcoming market trend.

    • Antihypertensive drugs, including diuretics, ACE inhibitors, vasodilators, calcium channel blockers, and beta-adrenergic blockers, are essential medications used to manage hypertension, or high blood pressure. The geriatric population, with its increased susceptibility to hypertension due to sedentary lifestyles and aging, is a significant consumer group for these drugs. Pharmaceutical companies are developing modified-release formulations of these antihypertensive drugs to ensure continuous 24-hour control of blood pressure. These formulations, such as sustained-release and controlled-release, maintain drug release over extended periods at varying rates. The market is expected to experience growth during the forecast period due to the increasing prevalence of hypertension and the development of new formulations.
    • Diuretics, like hydrochlorothiazide, chlorthalidone, and indapamide, remain popular choices due to their effectiveness in managing hypertension. ACE inhibitors, such as Valsartan tablets, and calcium channel blockers are also widely used. The market caters to various channels, including retail pharmacy, hospital pharmacy, e-commerce, and hospitals. E-commerce websites, online drug stores, and e-pharmacies have emerged as significant distribution channels, offering convenience and affordability to consumers. Pharmaceutical companies like Dr. Reddy's Laboratories continue to invest in research and development to expand their antihypertensive drug portfolios and cater to the evolving market dynamics.

      • What challenges does the Antihypertensive Drugs Industry face during its growth?

      Advent of wearable defibrillators is a key challenge affecting the industry growth.

    • The market encompasses various therapeutic classes, including diuretics, ACE inhibitors, vasodilators, calcium channel blockers, and beta-adrenergic blockers. These medications are primarily used for managing hypertension, a condition characterized by elevated blood pressure. The geriatric population, with their increased susceptibility to hypertension due to sedentary lifestyles and aging, significantly contributes to the market's growth. Market dynamics include patent expirations, leading to the availability of generic alternatives, and the increasing preference for retail pharmacies, hospital pharmacies, e-commerce, and online drug stores. For instance, brands like Dr. Reddy's Laboratories offer Valsartan tablets as a cost-effective alternative to branded ACE inhibitors. Thiazide diuretics, such as Hydrochlorothiazide, Chlorthalidone, and Indapamide, remain popular choices due to their effectiveness in managing hypertension.
    • Innovations in antihypertensive drugs continue, with research focusing on improving patient outcomes and reducing side effects. For example, new calcium channel blockers and beta-adrenergic blockers are being developed to provide better cardiovascular protection and minimize adverse reactions. The market is expected to grow steadily, driven by the increasing prevalence of hypertension and the availability of a wide range of effective and affordable treatment options.

      • Exclusive Customer Landscape

      The antihypertensive drugs market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the antihypertensive drugs market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

      Antihypertensive Drugs Market Share by Geography

       Customer Landscape

      Key Companies & Market Insights

      Companies are implementing various strategies, such as strategic alliances, antihypertensive drugs market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

      Abbott Laboratories - The company's portfolio encompasses various antihypertensive medications, including Tenormin (atenolol), Tenoretic (atenolol and thiazide diuretic), Zestril (lisinopril), and Zestoretic (lisinopril and hydrochlorothiazide). These drugs are utilized for managing hypertension, a prevalent health condition characterized by persistently elevated blood pressure levels. Antihypertensive agents function by inhibiting the production of angiotensin II, dilating blood vessels, or enhancing the excretion of sodium and water from the body. The market for antihypertensive drugs continues to expand due to the rising prevalence of hypertension and the increasing awareness of its associated risks. Additionally, advancements in drug development and delivery systems contribute to the market's growth.

      The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

      • Abbott Laboratories
      • AstraZeneca Plc
      • Aurobindo Pharma Ltd.
      • Bausch Health Companies Inc.
      • Bayer AG
      • Cipla Inc.
      • Daiichi Sankyo Co. Ltd.
      • Dr Reddys Laboratories Ltd.
      • GlaxoSmithKline Plc
      • Hetero Healthcare Ltd.
      • Johnson and Johnson Services Inc.
      • Lupin Ltd.
      • Merck and Co. Inc.
      • Noden Pharma DAC
      • Novartis AG
      • Pfizer Inc.
      • Sanofi SA
      • Sun Pharmaceutical Industries Ltd.
      • Viatris Inc.
      • Zydus Lifesciences Ltd.

      Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

      Research Analyst Overview

      Antihypertensive drugs are a significant segment of the pharmaceutical market, catering to the growing population suffering from hypertension, or high blood pressure. Hypertension is a chronic condition characterized by persistent elevated blood pressure levels, which, if left untreated, can lead to severe health complications, including heart disease, stroke, and kidney damage. The antihypertensive drug market encompasses various therapeutic classes, each with distinct mechanisms of action. Diuretics, for instance, promote the excretion of water and sodium from the body, thereby reducing blood volume and lowering blood pressure. ACE inhibitors, on the other hand, hinder the production of angiotensin II, a potent vasoconstrictor, thereby relaxing blood vessels and decreasing peripheral resistance.

      Vasodilators, another class of antihypertensive drugs, work by widening blood vessels, which in turn reduces the pressure on the walls of the arteries. Calcium channel blockers and beta-adrenergic blockers are other common classes of antihypertensive drugs that act by modulating the activity of calcium ions and adrenaline, respectively, to reduce blood pressure. The geriatric population represents a significant consumer base for antihypertensive drugs due to the increased prevalence of hypertension among older adults. Sedentary lifestyle, poor diet, and other age-related factors contribute to the development and progression of hypertension in this demographic. Market dynamics, including patent expirations, play a crucial role In the market.

      The expiration of patents on several blockbuster drugs has led to increased competition and price erosion In the market. For instance, the expiration of the patent on Valsartan tablets has resulted in a surge in generic competition, leading to price decreases and increased availability. The market can be segmented based on distribution channels, including retail pharmacies, hospital pharmacies, and e-commerce. Retail pharmacies dominate the market due to their widespread availability and convenience. However, the e-commerce segment is gaining traction due to the increasing popularity of online shopping and the convenience it offers. Hospitals and hospital pharmacies represent another significant distribution channel for antihypertensive drugs.

      These institutions are major consumers of antihypertensive drugs due to the high prevalence of hypertension among patients. E-commerce websites and online drug stores are also emerging as viable distribution channels, offering competitive pricing and convenience to consumers. In conclusion, the market is a dynamic and growing segment of the pharmaceutical industry. The market is driven by the increasing prevalence of hypertension, particularly among the geriatric population, and the availability of various therapeutic classes to address this condition. Market dynamics, including patent expirations, are also influencing the market landscape, leading to increased competition and price erosion. The distribution channels, including retail pharmacies, hospital pharmacies, and e-commerce, offer various advantages and challenges to market participants.

      Market Scope

      Report Coverage

      Details

      Page number

      143

      Base year

      2023

      Historic period

      		 2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 3.27%

      Market growth 2024-2028

      USD 6.23 billion

      Market structure

      Fragmented

      YoY growth 2023-2024(%)

      3.13

      Key countries

      US, Germany, UK, China, and Japan

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      What are the Key Data Covered in this Antihypertensive Drugs Market Research and Growth Report?

      • CAGR of the Antihypertensive Drugs industry during the forecast period
      • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
      • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
      • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
      • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
      • Thorough analysis of the market’s competitive landscape and detailed information about companies
      • Comprehensive analysis of factors that will challenge the antihypertensive drugs market growth of industry companies

      We can help! Our analysts can customize this antihypertensive drugs market research report to meet your requirements.

      Get in touch

       

      Table of Contents not available.

      Research Methodology

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      INFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases

      DATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts

      REPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape

      Interested in this report?

      Get your sample now to see our research methodology and insights!

      Download Now

      Frequently Asked Questions

      Antihypertensive Drugs market growth will increase by $ 0.01 tr during 2024-2028.

      The Antihypertensive Drugs market is expected to grow at a CAGR of 3.27% during 2024-2028.

      Antihypertensive Drugs market is segmented by Type( Systemic hypertension, Pulmonary hypertension)

      Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Merck and Co. Inc., Noden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Viatris Inc., Zydus Lifesciences Ltd. are a few of the key vendors in the Antihypertensive Drugs market.

      North America will register the highest growth rate of 55% among the other regions. Therefore, the Antihypertensive Drugs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

      US, Germany, UK, China, Japan

      • Availability of wide range of drugsPatients with hypertension are generally treated with drugs that can reduce blood volume (reducing central venous pressure and cardiac output) is the driving factor this market.
      • reduce systemic vascular resistance is the driving factor this market.
      • and reduce cardiac output by depressing heart rate and stroke volume. For example is the driving factor this market.
      • diuretic drugs decrease the blood volume by increasing urine output by the kidney. Similarly is the driving factor this market.
      • vasodilator drugs dilate blood vessels through the relaxation of smooth muscle in blood vessels. Cardioinhibitory drugs depress cardiac function by decreasing heart rate is the driving factor this market.
      • myocardial contractility is the driving factor this market.
      • or both is the driving factor this market.
      • which decreases cardiac output and arterial pressure. Similarly is the driving factor this market.
      • centrally acting sympatholytic drugs block sympathetic activity by binding to and activating alpha2 adrenoceptors. This reduces sympathetic outflow to the heart is the driving factor this market.
      • thereby decreasing cardiac output by reducing heart rate and contractility. Hence is the driving factor this market.
      • the availability of a wide range of therapeutics is offering specific treatment to patients with hypertension and driving the growth of the global antihypertensive drugs market during the forecast period. Some of the drugs available for the treatment of hypertension are listed below: is the driving factor this market.

      The Antihypertensive Drugs market vendors should focus on grabbing business opportunities from the Systemic hypertension segment as it accounted for the largest market share in the base year.